Prasol Chemicals IPO: Prasol Chemicals gets Sebi approval for Rs 800-cr IPO – Blue Barrows

Specialty chemical company Prasol Chemicals has received capital markets regulator Sebi’s go-ahead to raise as much as Rs 800 crore through an Initial Public Offering (IPO). The IPO comprises fresh issue of equity shares aggregating up to Rs 250 crore and an Offer-For-Sale (OFS) of up to 90 lakh equity shares by existing shareholders, according to the Draft Red Herring Prospectus (DRHP).

Prasol Chemicals, which filed its preliminary IPO papers with the regulator in April, obtained its “observation” letter on August 23, an update with the Securities and Exchange Board of India (Sebi) showed on Monday.

In Sebi’s parlance, its observation implies its go-ahead to launch initial share sale.

Going by the draft papers, the company may consider a further issue of equity shares aggregating up to Rs 50 crore. If such placement is completed, the fresh issue size will be reduced.

As per market sources, the company is likely to raise around Rs 700-800 crore through the IPO.

The proceeds from the fresh issue to the tune of Rs 160 crore will be used for payment of debt and Rs 30 crore for working capital requirements. Besides, funds will be used for general corporate purposes.

Since its inception, Prasol Chemicals, a forward integrated manufacturer of acetone and phosphorus derivatives, has expanded its business and scope of operations, evolving from a small-scale manufacturer to a big diversified specialty chemical company with a global presence.

Several acetone and phosphorus derivatives included in its portfolio are used in pharmaceuticals, synthesis of agrochemical active ingredients and formulations, besides their applications in home and personal care products such as sunscreens, shampoos, flavours, fragrances and disinfectants.

The company clocked a profit of Rs 50.10 crore in the nine-month period ended December 2021, Rs 25.08 crore in FY21 and Rs 37.77 crore in FY20. Its revenue from operations stood at Rs 626.93 crore for the nine-month period ended December 2021, Rs 595.54 crore in fiscal 2021 and Rs 531.24 crore in fiscal 2020.

and DAM Capital Advisors are the book-running lead managers to the issue.